Ruth O’Regan, MD
Ruth O’Regan, MD, Chief of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin, has been named the next Charles A. Dewey Professor and Chair of Medicine at the University of Rochester Medical Center’s (URMC) School of Medicine and Dentistry, pending approval by the University Board of Trustees. Dr. O’Regan brings more than 20 years of experience in academic medicine and a distinguished history of research and publication to her new role, which she will begin January 1, 2021.
Dr. O’Regan succeeds Paul Levy, MD, who is stepping down after a transformative decade as chair. The Department of Medicine has nearly 500 faculty across 14 divisions.
Paul Levy, MD
“I’m excited and honored to be joining the University of Rochester at this important time,” Dr. O’Regan said of her appointment. “URMC’s Department of Medicine has a solid research program, a strong commitment to education, and an impressive clinical enterprise.”
Clinical Background
Dr. O’Regan has held her current position at the University of Wisconsin since 2015. She is also an endowed Professor of Hematology/Oncology, Deputy Director of the University’s Carbone Cancer Center, Chief Scientific Officer of the Big Ten Cancer Research Consortium, and Vice Chair of the National Comprehensive Cancer Network’s Board of Directors.
Dr. O’Regan’s research centers on developing novel therapeutic approaches for treatment-resistant breast cancers, with a focus on triple-negative and endocrine-resistant metastatic breast cancers.
A native of Galway, Ireland, Dr. O’Regan grew up in Dublin. She earned her medical degree at University College, Dublin, and completed a residency in internal medicine at Mater Hospital, Dublin. She moved to the United States for subsequent residencies at the Medical College of Wisconsin and Northwestern
University and a fellowship in hematology/oncology at Northwestern University Robert H. Lurie Comprehensive Cancer Center.
Prior to joining the University of Wisconsin, she was Professor at Emory University School of Medicine in Atlanta, where she was the Louisa and Rand Glenn Family Chair in Breast Cancer Research and led the Translational Breast Cancer Research Program.
